Molecular Insight Pharmaceuticals Presents Positive Data From Clinical Studies Comparing Trofex(TM) and ProstaScint(R) for Detection of Metastatic Prostate Cancer Marketwire “Press Releases “ CAMBRIDGE, MA — (MARKET WIRE) — 10/14/10 — Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI), this week presented positive data from Phase 1 clinical studies comparing Trofex™ (123I-MIP-1072), its lead molecular imaging candidate […]